BSEGeneral3 Nov 2026 · 3 Nov 2026, 12:04 pm
Brooks Laboratories Limited has informed the BSE that the meeting of Board of Directors of the Company is scheduled on 07/11/2026, inter alia, to consider and approve take on records the unaudited financial results (Standalone and Consolidated)for the quarter and half year ended September 30,2026 along with limited review report of the statutory auditors of the company thereon.
Brooks Laboratories Ltd · 533543
✦ AI SummaryResults
Brooks Laboratories Ltd has informed the BSE that the meeting of Board of Directors is scheduled on 07/11/2026 to consider and approve unaudited financial results for the quarter and half year ended September 30,2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Brooks Laboratories Ltd - 533543 - Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1)
Attachments (1)
📄pdf
Download →
56ab31e4-6755-430e-91ed-ab956a418fd9.pdf
View document text
3rd November 2026
BSE Limited National Stock Exchange of India Ltd.
Listing Department Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai-400001 Bandra (E), Mumbai-400051
Scrip Code: 533543 Symbol: BROOKS
Sub: Intimation under Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015.
Dear Sir/ Madam,
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we hereby inform that the meeting of the Board of Directors of Brooks Laboratories Limited is scheduled
to be held on Saturday, 7th November 2026, inter alia to consider and approve the Unaudited standalone
and consolidated financial results for the quarter and half year ended 30th September 2026 along with
Limited Review Report of the Statutory Auditors of the Company thereon.
Further, referring to our communication dated 22nd September 2026, and pursuant to SEBI (Prohibition of
Insider Trading) Regulations, 2015 and Company’s Code of Conduct for Prevention of Insider Trading, the
trading window for all Directors and Designated Persons and their immediate relatives and specified
Connected Persons has been kept closed for dealing in the securities of the Company w.e.f. 1st October
2026. This is to further inform that the trading window will be re-opened for the aforesaid persons after
Forty Eight (48) hours after the declaration of Unaudited Financial Results to deal in the securities of the
Company.
Kindly take the same on record.
Thanking You.
Yours faithfully,
For BROOKS LABORATORIES LIMITED
Bhushan Singh Rana
Whole Time Director
DIN :10289384